Imstem
is a Connecticut-based biotechnology company that develops and commercializes stem cell based regenerative cellular therapies for the treatment of serious diseases... Read moreImstem
is a Connecticut-based biotechnology company that develops and commercializes stem cell based regenerative cellular therapies for the treatment of serious diseases... Read more
News
Feb 08, 2024
Pharamceutical Technology
Imstem: IMS-001 by Imstem Biotechnology for Secondary Progressive Multiple Sclerosis (SPMS): Likelihood of Approval
Sep 06, 2022
EIN Presswire
Press Release: Imstem : ImStem Biotechnology to present at 2022 Cell & Gene Meeting On the MESA
Jul 05, 2022
EIN Presswire
Press Release: Imstem Biotechnology : ImStem Files Opening Brief of Appeal to The U.S. Court of Appeals for The Federal Circuit Concerning Stem Cell Patents
Nov 30, 2021
MarketScreener
Imstem Biotechnology: AgeX Therapeutics' Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001
Nov 18, 2021
PR Newswire
Press Release: Imstem Biotechnology : ImStem Announces First US Multiple Sclerosis Patient Has Been Dosed with its IMS001
Oct 28, 2020
Business Wire
Press Release: Imstem Biotechnology : AgeX Therapeutics Sublicenses Stem Cell Line ESI-053 to ImStem Biotechnology for Development of Cell Therapy Candidate IMS001 for COVID-19 and Acute Respiratory Distress Syndrome
Jun 03, 2020
Pharmaceutical Business Review
Imstem Biotechnology: AgeX Therapeutics, ImStem Biotechnology sign non-binding letter of intent regarding investigational MSC candidate IMS001 for Covid-19
Jun 02, 2020
firstwordpharma
Imstem Biotechnology: AgeX Therapeutics and ImStem Biotechnology Sign Non-Binding Letter of Intent Regarding Investigational MSC Candidate IMS001 for COVID-19 and Other Causes of ARDS
Mar 20, 2020
BioPortfolio
Imstem Biotechnology: ImStem Biotechnology Announces FDA has Lifted the Clinical Hold on the Investigational New Drug Application for IMS001 for the Treatment of Multiple Sclerosis
Jun 10, 2014
FIERCE BIOTECH RESEARCH
Imstem Biotechnology: ImStem therapy reverses multiple sclerosis symptoms in mice
Imstem Competitors
1
2
3
4
5
6
7
8
9
10